82 results
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
for the interest for the nine-month period ended December 31, 2023.
Investigation of Patient Assistance Programs
In June 2019, the DOJ (through the U.S … was cooperating with the investigation and in December 2023, Takeda reached a settlement for an amount that is immaterial. The settlement had no material impact
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
Cancer Center and an expert in the management of TTP 1 TAK-755 has not been approved for the use or indications under investigation in clinical trials
S-8
EX-5.1
TAK
Takeda Pharmaceutical Co
28 Jun 23
Registration of securities for employees
6:35am
not made any independent investigation in respect of the matters which are the subject of such assumption or qualification.
Furthermore, our opinion stated
6-K
EX-99.1
23z45x83 8wntwmh
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
t8wr 8opt
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
3c9bpf5ts p8ul
30 May 23
Current report (foreign)
6:11am
6-K
seh5 5f955b
11 Jul 22
Current report (foreign)
6:05am
6-K
EX-99.1
rih kc7p96xwgdnnjln
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
8hikcvdtj1th
31 May 22
Current report (foreign)
12:00am
6-K
29aoke06 6k87wg
11 May 22
Current report (foreign)
6:06am
6-K
ter1kxp29py5ogk
10 Feb 22
Current report (foreign)
6:03am
6-K
ym31s37t8y68wmouj7w
3 Feb 22
Current report (foreign)
6:09am
6-K
2ynkim4 ok0w04zj
5 Nov 21
Current report (foreign)
6:02am
6-K
6gp0if7eeunohnkfs
1 Nov 21
Current report (foreign)
6:04am
S-8
EX-5.1
a06mp0ab9uh rst
28 Oct 21
Registration of securities for employees
6:33am
6-K
2qzp8c6f
28 Oct 21
Current report (foreign)
6:12am
6-K
ik1ird
1 Oct 21
Current report (foreign)
6:03am